![The Asian Pacific Association for the Study of the Liver [APASL]](https://www.apasl.info/wp-apasl/wp-content/themes/apasl/images/header/img_apasl_logo.png){kind=logo}
APASL Hepatology Webinar
-
Session:1
Diagnosis and Treatment Protocol of COVID-19 in China -
Session:2
Who have saved the first American from Covid 19? -
Session:3
Liver injury in Covid 19 -
Session:4
Liver transplantation perspective -
Session:5
How to manage HCC patients? -
Session:6
Hepatotoxicity of anti-Covid 19 therapy -
Session:7
To understand sytokine storm in COVID-19”
Episode 1
-
Session:1
The APASL Hepatology Webinar 2-1 has been successfully held! -
Session:2
The APASL Hepatology Webinar 2-2 has been successfully held! -
Session:3
The APASL Hepatology Webinar 2-3 has been successfully held! -
Session:4
The APASL Hepatology Webinar 2-4 has been successfully held! -
Session:5
The APASL Hepatology Webinar 2-5 has been successfully held! -
Session:6
The APASL Hepatology Webinar 2-6 has been successfully held! -
Session:7
The APASL Hepatology Webinar 2-7 has been successfully held!
Episode 2
-
Session:1
The APASL Hepatology Webinar 3-1 has been successfully held! -
Session:2
The APASL Hepatology Webinar 3-2 has been successfully held! -
Session:3
The APASL Hepatology Webinar 3-3 has been successfully held! -
Session:4
The APASL Hepatology Webinar 3-4 has been successfully held! -
Session:5
The APASL Hepatology Webinar 3-5 has been successfully held! -
Session:6
The APASL Hepatology Webinar 3-6 has been successfully held! -
Session:7
The APASL Hepatology Webinar 3-7 has been successfully held! -
Memorial Webinar
The APASL Memorial Webinar has been successfully held!
Episode 3
-
Session:1
Variceal Bleeding and Portal Hypertension -
Session:2
Autoimmune Hepatitis -
Session:3
Drug-induced Liver Injury -
Session:5
Drug Development in Hepatitis B -
Session:6
Editor’s Choice: Journal of Hepatology -
Session:7
Editor’s Choice: Hepatology -
Session:8
“Targeted therapy for HCC”
“Case presentation in real life and how to move forward
Episode 4
-
Session:1
Immune-tolerant phase: A remaining battlefield against hepatitis B -
Session:2
COVID-19 vaccination in patients with liver disease -
Session:2
Updates of Systemic Therapy for Hepatocellular Carcinoma -
Session:4
New drugs for hepatitis B under development -
Session:5
Mechanism and noninvasive assessment of liver fibrosis and steatosis -
Session:6
Microbiota and liver diseases -
Session:7
Updates of management for cirrhotic complications -
Session:8
Current and future management of NAFLD -
Session:10
Episode5-10 -
Session:11
New approaches for personalized surveillance of hepatocellular carcinoma
Episode 5
APASL Annual Meetings